Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 18/20 | 0.87 |
| ▸ | PGR | P06401 | 1/20 | 0.78 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.78 |
| ▸ | DRD1 | P21728 | 1/20 | 0.78 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.78 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.78 |
| ▸ | FPR3 | P25089 | 1/20 | 0.78 |
| ▸ | PDE4A | P27815 | 1/20 | 0.78 |
| ▸ | GPR183 | P32249 | 1/20 | 0.78 |
| ▸ | DRD3 | P35462 | 1/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.78 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.78 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.78 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.78 |
| ▸ | P2RY13 | Q9BPV8 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21117018 | 1.00 | P2RY12 (0.87) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL21803791 | 1.00 | P2RY12 (0.87) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL6999645 | 1.00 | P2RY12 (0.87) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL29349818 | 1.00 | P2RY12 (0.87) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL29583907 | 1.00 | P2RY12 (0.87) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL24418219 | 1.00 | P2RY12 (0.87) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL4912859 | 0.95 | P2RY12 (0.79) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL3616697 | 0.95 | P2RY12 (0.79) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL29688114 | 0.95 | P2RY12 (0.79) | P2RY12PGRADORA3CHRM1DRD1 | |
| SCHEMBL17736341 | 0.94 | P2RY12 (0.78) | P2RY12PGRADORA3CHRM1DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707344-A2 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CM4Cure s.a. (BE) | 2026-03-11 | — | — | EP | claimed |
| EP-4701418-A1 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CM4Cure s.a. (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4680295-A1 | NANOGEL COMPRISING BIOACTIVE MOLECULES, THERAPEUTIC MOLECULES OR DRUGS TOGETHER WITH AN AMPHIPHILIC MOLECULE | CM4Cure s.a. (BE) | 2026-01-21 | — | — | EP | claimed |
| US-20250387398-A1 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CM4CURE S A (BE) | 2025-12-25 | — | — | US | claimed |
| US-20250375453-A1 | HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CM4CURE S A (BE) | 2025-12-11 | — | — | US | claimed |
| WO-2025036832-A1 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CMD-COAT SA (BE) | 2025-02-20 | — | — | WO | claimed |
| WO-2024188572-A1 | NANOGEL COMPRISING BIOACTIVE MOLECULES, THERAPEUTIC MOLECULES OR DRUGS TOGETHER WITH AN AMPHIPHILIC MOLECULE | CMD-COAT SA (BE) | 2024-09-19 | — | — | WO | claimed |
| EP-4431124-A1 | NANOGEL COMPRISING BIOACTIVE MOLECULES, THERAPEUTIC MOLECULES OR DRUGS TOGETHER WITH AN AMPHIPHILIC MOLECULE, PARTICULARLY A VITAMIN-E DERIVATIVE | CMD-COAT SA (BE) | 2024-09-18 | — | — | EP | claimed |
| EP-4003433-A1 | NEW USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | Université de Liège (BE) | 2022-06-01 | — | — | EP | claimed |
| US-10905691-B2 | Use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection | Université de Liège (BE) | 2021-02-02 | — | — | US | claimed |
| EP-3509598-B1 | NEW USE OF TRIAZOLO(4,5-D)PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTION | UNIV LIEGE (BE) | 2020-10-07 | — | — | EP | claimed |
| US-20200093826-A1 | NEW USE OF TRIAZOLO(4,5 D)PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTION | GESVAL S.A. (BE) | 2020-03-26 | — | — | US | claimed |
| EP-4707344-A2 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CM4Cure s.a. (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4701418-A1 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CM4Cure s.a. (BE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4680295-A1 | NANOGEL COMPRISING BIOACTIVE MOLECULES, THERAPEUTIC MOLECULES OR DRUGS TOGETHER WITH AN AMPHIPHILIC MOLECULE | CM4Cure s.a. (BE) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680245-A1 | TICAGRELOR IV FORMULATIONS FOR USE IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA | Hyloris Developments SA (BE) | 2026-01-21 | — | — | EP | disclosed |
| WO-2016050867-A1 | ANTIBODIES TO TICAGRELOR AND METHODS OF USE | MEDIMMUNE LIMITED (GB) | 2016-04-07 | — | — | WO | disclosed |
| US-9221829-B2 | Synthesis of triazolopyrimidine compounds | LEK PHARMACEUTICALS D.D. (SI) | 2015-12-29 | — | — | US | disclosed |
| US-20150005498-A1 | Synthesis of Triazolopyrimidine Compounds | LEK PHARMACEUTICALS D.D. (SI) | 2015-01-01 | — | — | US | disclosed |
| WO-2013037942-A1 | SYNTHESIS OF TRIAZOLOPYRIMIDINE COMPOUNDS | LEK PHARMACEUTICALS D.D. (SI) | 2013-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387398-A1 | NEW HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | THPO, IL17A, TEAD3 | P2RY12 199/4885PGR 807/4885ADORA3 526/4885 |
| US-20200093826-A1 | NEW USE OF TRIAZOLO(4,5 D)PYRIMIDINE DERIVATIVES FOR PREVENTION AND TREATMENT OF BACTERIAL INFECTION | XDH, FPR3, HRH3 | P2RY12 1840/4885PGR 1571/4885ADORA3 247/4885 |
| US-20250375453-A1 | HIGH-EFFICIENCY ANTIMICROBIAL COMPOSITION | CUTA, PRF1, CD68 | P2RY12 1256/4885PGR 1998/4885ADORA3 2242/4885 |
| US-10905691-B2 | Use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection | XDH, FPR3, HRH3 | P2RY12 1935/4885PGR 1453/4885ADORA3 284/4885 |
| US-20150005498-A1 | Synthesis of Triazolopyrimidine Compounds | TBXAS1, TYMS, TBXA2R | P2RY12 76/4885PGR 2242/4885ADORA3 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.